Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Colorcon
Merck
AstraZeneca
Harvard Business School

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Palifosfamide

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Palifosfamide: Patents, clinical trial progress, indications

Palifosfamide is an investigational drug.

There have been 8 clinical trials for Palifosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Testicular Neoplasms, Sarcoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are Ziopharm, Indiana University School of Medicine, and [disabled in preview].

There are sixteen US patents protecting this investigational drug and one hundred and thirty-nine international patents.

Recent Clinical Trials for Palifosfamide
TitleSponsorPhase
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.ZiopharmPhase 2
Palifosfamide in Treating Patients With Recurrent Germ Cell TumorsZiopharmPhase 2
Palifosfamide in Treating Patients With Recurrent Germ Cell TumorsIndiana University School of MedicinePhase 2

See all Palifosfamide clinical trials

Clinical Trial Summary for Palifosfamide

Top disease conditions for Palifosfamide
Top clinical trial sponsors for Palifosfamide

See all Palifosfamide clinical trials

US Patents for Palifosfamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Palifosfamide   See Pricing Formulations and methods of reducing toxicity of antineoplastic agents BioNumerik Pharmaceuticals, Inc. (San Antonio, TX)   See Pricing
Palifosfamide   See Pricing Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents DEKK-TEC, Inc. (New Orleans, LA)   See Pricing
Palifosfamide   See Pricing Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents Ziopharm Oncology, Inc. (Boston, MA)   See Pricing
Palifosfamide   See Pricing Phosphoramidate alkylator prodrugs Threshold Pharmaceuticals, Inc. (Redwood CIty, CA)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Palifosfamide

Drugname Country Document Number Estimated Expiration Related US Patent
Palifosfamide Austria 237337 2014-11-14   See Pricing
Palifosfamide Austria 262329 2014-11-14   See Pricing
Palifosfamide Australia 1090899 2014-11-14   See Pricing
Palifosfamide Australia 4116896 2014-11-14   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Express Scripts
Baxter
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.